{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-24-003900","form_type":"8-K","ticker":"ANIK","cik":"0000898437","company_name":"Anika Therapeutics, Inc.","filed_at":"2024-07-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.238745+00:00","generated_at":"2026-05-31T21:57:46.797271+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Anika Therapeutics stockholders elect directors and ratify auditor at 2024 annual meeting","bullets":["Elected Sheryl L. Conley, William R. Jellison, Stephen O. Richard as Class I directors (2027 term).","Ratified Deloitte & Touche LLP as independent auditor: 12,337,376 for, 43,654 against.","Say-on-pay proposal passed on a non-binding advisory basis: 11,020,273 for, 129,717 against.","Annual meeting turnout: 12,387,064 shares voted, representing 83.37% of entitled voting power.","No contested solicitations; all board proposals carried with substantial majority support."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-24-003900","json":"https://secwatch.observer/filing/0001171843-24-003900.json","markdown":"https://secwatch.observer/filing/0001171843-24-003900.md","text":"https://secwatch.observer/filing/0001171843-24-003900.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/898437/000117184324003900/0001171843-24-003900-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/898437/000117184324003900/f8k_071124.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T21:57:46.797271+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}